Not applicableUnknownNCT04353050What this trial is testingAtypical MOLes and Melanoma Early Detection Study (MoleMed)Who this might be right forMelanomaMelanoma (Skin)Moles+9 more Russian Academy of Medical Sciences 350
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Not applicableStudy completedNCT06079619What this trial is testingComparison of Dermatoscopy X400 Interpreted by 6 Non-dermatologists and an Artificial Intelligence Software Skin Artificial Intelligence Versus Dermatoscopy x 20Who this might be right forGenital TumorPigmented Lesions Centre Hospitalier Universitaire de Saint Etienne 157
Early research (Phase 1)Study completedNCT02858869What this trial is testingPembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain MetastasesWho this might be right forMetastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal Melanoma+4 more Emory University 25
Early research (Phase 1)Ended earlyNCT01769222What this trial is testingIpilimumab and Local Radiation for Selected Solid TumorsWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Stanford University 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03235245What this trial is testingImmunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and BinimetinibWho this might be right forUnresectable Stage III MelanomaStage IV Melanoma European Organisation for Research and Treatment of Cancer - EORTC 271
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Not applicableActive Not RecruitingNCT06863870What this trial is testingAssessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous MelanomaWho this might be right forMelanoma Neoplasms IRCCS Azienda Ospedaliero-Universitaria di Bologna 35
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00002980What this trial is testingDecitabine in Treating Patients With Melanoma or Other Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more California Cancer Consortium
Large-scale testing (Phase 3)Active Not RecruitingNCT02506153What this trial is testingPhysician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by SurgeryWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+6 more National Cancer Institute (NCI) 1,301
Testing effectiveness (Phase 2)Looking for participantsNCT06961357What this trial is testingClinical Trial of CD40L-augmented TIL for Patients With Advanced MelanomaWho this might be right forMelanoma H. Lee Moffitt Cancer Center and Research Institute 36
Not applicableStudy completedNCT00899496What this trial is testingLaboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy ParticipantsWho this might be right forCancer Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT05661955What this trial is testingInvestigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.Who this might be right forUrothelial CarcinomaRenal Cell CarcinomaMelanoma+1 more BeiGene 113
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725What this trial is testingLow Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06797297What this trial is testingEvaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic TherapyWho this might be right forMelanoma Innovent Biologics (Suzhou) Co. Ltd. 180
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Not applicableWithdrawnNCT00093678What this trial is testingCelecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWho this might be right forCachexiaLymphomaMelanoma (Skin)+4 more Eastern Cooperative Oncology Group
Early research (Phase 1)Active Not RecruitingNCT03025256What this trial is testingIntravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseWho this might be right forAcral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more M.D. Anderson Cancer Center 75